593 related articles for article (PubMed ID: 15313394)
1. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
[TBL] [Abstract][Full Text] [Related]
2. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.
Alexia C; Lasfer M; Groyer A
Ann N Y Acad Sci; 2004 Dec; 1030():219-29. PubMed ID: 15659801
[TBL] [Abstract][Full Text] [Related]
3. The role of the IGF axis in hepatocarcinogenesis.
Scharf JG; Braulke T
Horm Metab Res; 2003; 35(11-12):685-93. PubMed ID: 14710347
[TBL] [Abstract][Full Text] [Related]
4. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
Huynh H; Chow PK; Ooi LL; Soo KC
Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of PI-3' kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis.
Alexia C; Bras M; Fallot G; Vadrot N; Daniel F; Lasfer M; Tamouza H; Groyer A
Ann N Y Acad Sci; 2006 Dec; 1090():1-17. PubMed ID: 17384242
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II.
Kuo WW; Liu CJ; Chen LM; Wu CH; Chu CH; Liu JY; Lu MC; Lin JA; Lee SD; Huang CY
Apoptosis; 2006 Jul; 11(7):1075-89. PubMed ID: 16699953
[TBL] [Abstract][Full Text] [Related]
7. Induction of glutathione transferase in insulin-like growth factor type I receptor-overexpressed hepatoma cells.
Lee JY; Han CY; Yang JW; Smith C; Kim SK; Lee EY; Kim SG; Kang KW
Mol Pharmacol; 2007 Oct; 72(4):1082-93. PubMed ID: 17615245
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the IGF axis components in isolated rat hepatic stellate cells.
Scharf JG; Knittel T; Dombrowski F; Müller L; Saile B; Braulke T; Hartmann H; Ramadori G
Hepatology; 1998 May; 27(5):1275-84. PubMed ID: 9581681
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis.
Singleton JR; Randolph AE; Feldman EL
Cancer Res; 1996 Oct; 56(19):4522-9. PubMed ID: 8813151
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL
Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I stimulates H4II rat hepatoma cell proliferation: dominant role of PI-3'K/Akt signaling.
Alexia C; Fourmatgeat P; Delautier D; Groyer A
Exp Cell Res; 2006 Apr; 312(7):1142-52. PubMed ID: 16487514
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
[TBL] [Abstract][Full Text] [Related]
14. Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis.
Nussbaum T; Samarin J; Ehemann V; Bissinger M; Ryschich E; Khamidjanov A; Yu X; Gretz N; Schirmacher P; Breuhahn K
Hepatology; 2008 Jul; 48(1):146-56. PubMed ID: 18537183
[TBL] [Abstract][Full Text] [Related]
15. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
16. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
17. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.
Fu P; Thompson JA; Leeding KS; Bach LA
J Cell Biochem; 2007 Jan; 100(1):58-68. PubMed ID: 16888814
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
20. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
